Acquired Company

Chiesi Farmaceutici S.p.A. completed the acquisition of Amryt Pharma Plc on 4/12/2023 for US$14.50 per ADS plus Contingent Value Rights of up to US$2.50 per ADS, representing a total transaction value of up to US$1.48 billion.

Amryt Pharma PLC operates as a biopharmaceutical company. The Company develops and delivers treatments for rare and orphan diseases. Amryt Pharma serves customers worldwide. Show more

Dept, Woodgreen Underground Station, London, N22 8HH, United Kingdom

www.amrytpharma.com

Pharmaceutical Preparation Manufacturing

Manufacturing

Start AI Chat

Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$14.70

Open

$14.70

Volume

N/A

Day Range

$14.70 - $14.70

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

0.08%

Institutional Own.

77.31%

Qtr Updated

06/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Juxtapid/Lojuxta (lomitapide) Details HoFH (Homozygous Familial Hypercholesterolemia)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Myalept (metreleptin injections) Details GL (Generalized Lipodystrophy)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Mycapssa (octreotide) Details Acromegaly	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.